An Independent Review
Home About Us Contact Us Index Search Consumer Topics Back Issues

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

vaccination, immunisation - see also injections
  • childhood programs 17(4) 91-4
    		•
  • cholera - Dukoral (New drug) 27(6) 159-65
    		•
  • Orochol (New drug) 23(4) 84-7
    		•
  • contraindications 17(4) 91-4
    		•
  • diphtheria, tetanus, pertussis, hepatitis B, polio and Haemophilus influenzae type b - Infanrix penta, Infanrix hexa and Infanrix IPV (New combinations) 27(6) 159-65
    		•
  • egg protein allergy (letter) 18(2) 27-9
    		•
  • hepatitis A - Avoxim (New brand) 23(5) 110-1
    		•
  • hepatitis B - abnormal laboratory results and immunology 21(3) 72-5
    		•
  • dental implications 21(3) 79
    		•
  • hepatitis B - HB-VAX-II (New formulation) 24(4) 100-2
    		•
  • hepatitis B - PedvaxHIB b (New formulation) 23(3) 64-7
    		•
  • HIV infection and travel 23(5) 107-9
    		•
  • human papillomavirus
  • Cervarix (New drug) 30(5) 133-5
    		•
  • Gardasil (New drug) 29(5) 138-43
    		•
  • influenza immunisation 25(1) 5-7
    		•
  • letter 25(3) 51-3
    		•
  • influenza vaccination for healthy adults 30(2) 35-7
    		•
  • letter 30(5) 116
    		•
  • PBAC question 30(3) 83
    		•
  • influenza vaccination in pregnancy - information services 24(5) 116-9
    		•
  • letters 25(4) 79-80; 25(1) 4
    		•
  • Japanese encephalitis - JE-VAX (New drug) 22(3) 70-1
    		•
  • capsular polysaccharide typhoid vaccine - Typhim Vi (New drug) 17(2) 30-2
    		•
  • managing painful paediatric procedures 29(4) 94-6
    		•
  • measles - childhood immunisation 17(4) 91-4
    		•
  • meningococcal disease 26(3) 56-8
    		•
  • meningococcal group C conjugate vaccine - Meningitec (New drug) 24(6) 155-8
    		•
  • Menjugate (New formulation) 25(6) 147-51
    		•
  • NeisVac-C (New formulation) 25(6) 147-51
    		•
  • meningococcal vaccine - Mencevax (New drug) 17(1) 6-8
    		•
  • mumps - childhood immunisation 17(4) 91-4
    		•
  • NHMRC schedule 17(4) 95
    		•
  • in doctor's bag supplies (PBAC question) 19(3) 75
    		•
  • pertussis - childhood immunisation 17(4) 91-4
    		•
  • letter - contraindications 18(3) 56-7
    		•
  • pneumococcal - recommendations 17(2) 41
    		•
  • letter 18(1) 4-7
    		•
  • pneumococcal conjugate vaccine - Prevenar (New drug) 24(3) 71-5
    		•
  • poliomyelitis - childhood immunisation 17(4) 91-4
    		•
  • rabies - Rabipur (New drug) 29(1) 25-7
    		•
  • rotavirus vaccine - Rotarix (New drug) 29(4) 112-5
    		•
  • rotavirus vaccine - RotaTeq (New drug) 29(4) 112-5
    		•
  • rubella - childhood immunisation 17(4) 91-4
    		•
  • cholera - Orochol (New drug) 23(4) 84-7
    		•
  • specific vaccines - varicella vaccine 28(1) 2-5
    		•
  • letters 28(5) 113-5; 28(3) 55-8
    		•
  • tetanus vaccine in management of animal and human bites 29(1) 6-8
    		•
  • triple antigen - Boostrix (New proprietary brand) 24(4) 100-2
    		•
  • tuberculosis - BCG vaccine 26(6) 144-6; 26(6) 146
    		•
  • letters 27(2) 28-33
    		•
  • use of two needles (letter) 22(2) 28-31
    		•
  • vaccination, immunisation (see also injections) 22(4) 95-8
    		•
  • varicella
  • childhood immunisation 17(4) 91-4
    		•
  • vaccination (letter) 30(5) 116
    		•
  • Valrix (New drug) 23(2) 45-6
    		•
  • zoster virus vaccine - Zostavax (New drug) 31(1) 24-7
    		•
    vaginitis
  • Candida vaginitis management 24(3) 62-4
    		•
  • management 24(3) 59-61
    		•
    valaciclovir
  • acyclovir ester - herpes zoster - Valtrex (New drug) 19(4) 108-11
    		•
    Valcyte
  • see valganciclovir 25(6) 147-51
    		•
    valdecoxib
  • parecoxib - postoperative analgesia - Dynastat (New drug) 25(4) 94-9
    		•
    Valette
  • see dienogest/ethinyloestradiol 30(2) 50-55
    		•
    valganciclovir
  • cytomegalovirus retinitis - Valcyte (New drug) 25(6) 147-51
    		•
    valproic acid
  • in bipolar disorders 30(3) 70-3
    		•
  • clinical use of antiepileptics 17(1) 9-12
    		•
    vancomycin
  • antibiotic resistance and animal husbandry (editorial) 24(2) 26-7
    		•
  • teicoplanin comparison - Targocid (New drug) 18(1) 7-9
    		•
  • therapeutic drug monitoring (letter) 20(3) 57-60
    		•
    Vaniqa
  • see eflornithine hydrochloride 29(3) 84-7
    		•
    vardenafil
  • advertising - Medicines Australia code of conduct breaches 30(6) 154
    		•
  • erectile dysfunction - Levitra (New drug) 26(3) 68-71
    		•
    varenicline
  • Champix - smoking cessation (New drug) 31(1) 24-7
    		•
    Varicella infections
  • childhood immunisation 17(4) 91-4
    		•
    varicella vaccine
  • frequently asked questions 28(1) 2-5
    		•
  • letters 28(5) 113-5; 28(3) 55-8
    		•
  • vaccination (letter) 30(5) 116
    		•
  • Varilix (New drug) 23(2) 45-6
    		•
    varices
  • management of gastrointestinal haemorrhage 28(3) 62-6
    		•
    varicose veins
  • laureth-9 - Aethoxysklerol (New drug) 25(1) 20-3
    		•
    Varilix
  • see varicella vaccine 23(2) 45-6
    		•
    vascular endothelial growth factor
  • angiogenesis inhibitors in cancer 29(1) 9-12
    		•
    Vasocardol CD
  • see diltiazem 22(6) 147-51
    		•
    vasoconstrictors
  • interactions with psychotropic drugs and dentistry 30(4) 98-101
    		•
    vasodilators
  • ACE inhibitors in heart failure (editorial) 19(1) 2-3
    		•
  • clinical pharmacology of calcium channel antagonists 20(1) 5-8
    		•
  • epoprostenol - primary pulmonary hypertension - Flolan (New drug) 25(6) 147-51
    		•
  • iloprost - Ventavis - pulmonary hypertension (New drug) 27(3) 76-9
    		•
  • nicorandil - angina - Ikorel (New drug) 22(1) 20-3
    		•
  • nitric oxide - neonatal respiratory failure - INOmax (New drug) 31(1) 24-7
    		•
    Vectavir
  • see penciclovir 20(3) 77-9
    		•
    Velcade
  • see bortezomib 29(3) 84-7
    		•
    venlafaxine
  • antidepressant - Efexor (New drug) 19(3) 81-3
    		•
  • Efexor (New formulation) 22(1) 20-3
    		•
  • pharmacology of serotonin reuptake inhibitors 22(5) 106-8
    		•
    Venofer
  • see iron sucrose 28(2) 49-51
    		•
    venography
  • deep vein thrombosis 21(3) 76-9
    		•
    venomous fish
  • management of puncture injuries 30(5) 117-21
    		•
    Ventavis
  • see iloprost 27(3) 76-9
    		•
    ventricular tachycardia
  • drugs which prolong the QTC interval 25(3) 63-5
    		•
    verapamil
  • clinical pharmacology of calcium channel antagonists 20(1) 5-8
    		•
  • in doctor's bag supplies (PBAC question) 20(4) 86-7
    		•
  • new brand Anpec SR 19(3) 81-3
    		•
    verteporfin
  • macular degeneration 25(5) 116-9
    		•
  • macular degeneration - Visudyne (New drug) 23(6) 137-9
    		•
    vertigo
  • diagnosis and management 28(4) 94-7
    		•
  • dental treatment (letter) 28(6) 136-9
    		•
    Vesanoid
  • see tretinoin 19(2) 38-40
    		•
    Vesicare
  • see solifenacin succinate 29(5) 138-43
    		•
    vestibular disorders
  • diagnosis and management of dizziness 28(4) 94-7
    		•
    Vfend
  • see voriconazole 26(4) 94-5
    		•
    Viagra
  • see sildenafil 21(4) 108-11
    		•
    Videx EC
  • see didanosine 24(4) 100-2
    		•
    Vietnam Veterans Association
  • and post-traumatic stress disorder 22(2) 34-6
    		•
    vigabatrin
  • clinical use of antiepileptics 17(1) 9-12
    		•
  • in epilepsy 22(3) 61-3
    		•
    vinorelbine
  • breast and lung cancer - Navelbine (New drug) 21(2) 49-55
    		•
  • letter 21(4) 87-91
    		•
    Vioxx
  • see rofecoxib 23(6) 137-9
    		•
    Viracept
  • see nelfinavir 21(2) 49-55
    		•
    Viramune
  • see nevirapine 24(1) 20-3; 20(4) 101-3
    		•
    Viread
  • see tenofovir 25(6) 147-51
    		•
    vision disorders
  • xanthopsia and digoxin dosages 29(6) 153
    		•
    Vistide
  • see cidofovir 22(2) 43-7
    		•
    Visudyne
  • see verteporfin 23(6) 137-9
    		•
    vitamin B12 and folate
  • abnormal laboratory results 22(1) 16-8
    		•
    vitamin D
  • deficiency - calcium supplementation - osteoporosis 26(6) 126-7
    		•
    vitamin K
  • see phytomenadione 23(2) 45-6
    		•
    vitamin supplements
  • antioxidants and nutrition 22(6) 142-4
    		•
    vitamins
  • management of undernutrition 24(5) 113-5
    		•
    Voltaren
  • see diclofenac 19(4) 92-3
    		•
    Voluven
  • see pentastarch 30(4) 107-11
    		•
    vomiting
  • aprepitant - Emend - cancer chemotherapy (New drug) 27(3) 76-9
    		•
  • granisetron - Kytril (New drug) 27(4) 101-5
    		•
    von Hippel Lindau syndrome
  • genetic testing and information (letter) 19(1) 3-6
    		•
    voriconazole
  • antifungal - Vfend (New drug) 26(4) 94-5
    		•
    vulvovaginitis
  • butoconazole nitrate - Gynazole - candidal vulvovaginitis (New drug) 29(5) 138-43
    		•
  • Candida vulvovaginitis management 24(3) 62-4
    		•
  • diagnosis and management in childhood 28(4) 88-90
    		•
  • management 24(3) 59-61
    		•
    Home     Contact Us     Useful Links     Copyright     Privacy     Web Manager